Menu

EMAP
Grup d’Estudis de Medicament en Atenció Primària (EMAP)

Group leader
40882722S - Rosa Morros Pedrós - OK retall
Rosa Morros Pedrós
rmorros@idiapjgol.org
avatar_grups_recerca.png

Projects

Group projects

Modificación de la prescripción de ISGLT2 durante la pandemia COVID. Análisis de la prescripción en ECAP

  • Principal investigators: Cristina Vedia Urgell
  • Code: 4R20/191
  • Start year: 2020
  • Funders: ICS - Institut Català de la Salut

Estudi de resultats en salut en diabetis mellitus tipus 2

  • Principal investigators: Maria Giner Soriano
  • Code: 4R21/022
  • Start year: 2021
  • Funders: Institut d’Investigació en Atenció Primària Jordi Gol i Gurina (IDIAPJGol)

Post-Authorisation Safety Study of AZD1222. A post-authorisation/post-marketing observational study to evaluate the association between exposure to AZD1222 and safety concerns using existing secondary health data sources

  • Principal investigators: Rosa Morros Pedrós, Maria Giner Soriano
  • Code: 4R21/075
  • Start year: 2021
  • Funders: Research Triangle Institute (RTI)

Retrospective Longitudinal Study on Edoxaban in Patients with Non-Valvular Atrial Fibrillation in Europe

  • Principal investigators: Rosa Morros Pedrós, Maria Giner Soriano
  • Code: 4R21/145
  • Start year: 2021
  • Funders: Syneos Health, LLC

Post-authorisation Safety Study of Rimegepant in Patients with Migraine and History of Cardiovascular Disease in European Countries

  • Principal investigators: Maria Giner Soriano
  • Code: 4R22/026
  • Start year: 2022
  • Funders: Research Triangle Institute (RTI)

Board of Trustees

Collaborators

Accreditations